Skip to main content
. 2017 Mar 7;21(4):269–276. doi: 10.1007/s10151-017-1599-7

Table 1.

Primary and secondary success rates after FiLaC™

Patient characteristics n Primary healing Secondary healing#
Yes (%) No (%) HRR (95% CI) p $ Yes (%) No (%) HRR (95% CI) p $
n 117 75 (64.1) 42 (35.9) 103 (88.0) 14 (12.0)
Age& 47 (19) 45.5 (19) 0.278 46 (17) 42.5 (20) 0.980
Sex
 Male 82 51 (62.2) 31 (37.8) *** 71 (86.6) 11 (13.4) ***
 Female 35 24 (68.5) 11 (31.5) 1.10 (0.83,1.50) 0.537 32 (91.4) 3 (8.6) 1.06 (0.92,1.21) 0.550
Aetiology
 Cryptoglandular 104 66 (63.5) 38 (36.5) *** 91 (87.5) 13 (12.5) ***
 Crohn 13 9 (69.2) 4 (30.8) 1.09 (0.74,1.61) 0.768 12 (92.3) 1 (7.7) 1.05 (0.89,1.25) 1.000
Park classification
 I 8 8 (100.0) 0 (0.0) 1.63 (1.39,1.93) 0.048 8 (100.0) 0 (0.0) 1.12 (1.05,1.21) 1.000
 II 90 55 (61.1) 35 (38.9) *** 80 (88.9) 10 (11.1) ***
 III 13 8 (61.5) 5 (38.5) 1.01 (0.64,1.60) 1.000 10 (76.9) 3 (23.1) 0.87 (0.64,1.18) 0.211
 IV 6 4 (66.7) 2 (33.3) 1.09 (0.61,1.97) 1.000 5 (83.3) 1 (16.7) 0.94 (0.65,1.35) 0.528
Closure technique
 MSAF 51 34 (66.7) 17 (33.3) 1.02 (0.77,1.35) 1.000 46 (90.2) 5 (9.8) 1.04 (0.91,1.20) 0.760
 Anodermal flap 52 34 (65.4) 18 (34.6) *** 45 (86.5) 7 (13.5) ***
 Mucosal flap 2 1 (50.0) 1 (50.0) 0.76 (0.19,3.10) 1.000 1 (50.0) 1 (50.0) 0.58 (0.14,2.32) 0.277
 Suture closure 12 6 (50.0) 6 (50.0) 0.76 (0.42,1.39) 0.341 11 (91.7) 1 (8.3) 1.06 (0.87,1.30) 1.000
Prior fistula repair§
 Yes 16 9 (56.3) 7 (43.7) 0.86 (0.55,1.36) 0.577 13 (81.3) 3 (18.7) 0.91 (0.71,1.16) 0.405
 No 101 66 (65.3) 35 (34.7) *** 90 (89.1) 11 (10.9) ***

HRR healing rate ratio, MSAF mucosal–submucosal advancement flap

$ p value from Fisher’s exact test except for age, where the p value is from a Kruskal–Wallis test

***  Indicates reference group; 9% CI 95% confidence interval

# Defined as healing at the end of study

§ Defined as any surgery except I/D of abscess and seton replacement

& Median (interquartile range)